Amol Akhade/LinkedIn
Jul 5, 2024, 02:06
Amol Akhade: New combinations that are tested in MSS CRC
Amol Akhade shared on X:
“What are the new combinations that are tested in MSS CRC?
- Anti PD1 plus Anti CTLA4
- TKI plus Anti PD1
- Anti PD1 plus Anti CTLA4 plus TKI”
Source: Amol Akhade/X
Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata Memorial Hospital.
He specialises in chemotherapy for hematological cancers as well as solid tumors. He also specialises in allogenic and autologous bone marrow transplant. Currently he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 23:41
Jan 16, 2025, 23:37
Jan 16, 2025, 23:35
Jan 16, 2025, 23:33
Jan 16, 2025, 23:21
Jan 16, 2025, 23:19